More Ultrasound-Guided Percutaneous Microwave Ablation Leads to Higher Immune-Related Gene Expression and Boosts PD-1 Monoclonal Antibodies for Liver Cancer
出版年份 2023 全文链接
标题
More Ultrasound-Guided Percutaneous Microwave Ablation Leads to Higher Immune-Related Gene Expression and Boosts PD-1 Monoclonal Antibodies for Liver Cancer
作者
关键词
-
出版物
ULTRASOUND IN MEDICINE AND BIOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-10-21
DOI
10.1016/j.ultrasmedbio.2023.09.018
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Microwave ablation combined with anti-PD-1 therapy enhances systemic antitumor immunity in a multitumor murine model of Hepa1-6
- (2022) Songjiang Huang et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
- (2022) Uasim Harkus et al. SEMINARS IN CANCER BIOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma
- (2021) Won‐Mook Choi et al. LIVER INTERNATIONAL
- Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer
- (2021) Wenbin Zhou et al. Journal for ImmunoTherapy of Cancer
- Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B
- (2021) Yanan Gao et al. JOURNAL OF HEPATOLOGY
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Yunpeng Yang et al. LANCET ONCOLOGY
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
- (2020) Shukui Qin et al. LANCET ONCOLOGY
- DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25
- (2020) Linbin Yang et al. NATURE
- Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
- (2020) Lin Shen et al. Journal for ImmunoTherapy of Cancer
- Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma
- (2020) Katharina Leuchte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study
- (2020) Ning Lyu et al. Frontiers in Oncology
- Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
- (2019) Thomas Yau et al. JOURNAL OF HEPATOLOGY
- Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
- (2019) Chen Lu et al. Molecular Cancer
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
- (2019) Hongbo Wang et al. Journal of Hematology & Oncology
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model
- (2018) J. Zhu et al. Diagnostic and Interventional Imaging
- Tremelimumab in combination with microwave ablation in patients with refractory biliary tract cancer
- (2018) Changqing Xie et al. HEPATOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer
- (2017) Li Li et al. Journal of Translational Medicine
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Immuno-thermal ablations – boosting the anticancer immune response
- (2017) Ryan Slovak et al. Journal for ImmunoTherapy of Cancer
- Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis
- (2016) Antonio Facciorusso et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
- (2014) B. Hu et al. CLINICAL CANCER RESEARCH
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started